aspirin: reduce cancer risk

Property	Similarity
reduce cancer risk	1.00
reduce risk	0.91
prevent cancer	0.88
reduce pain	0.82
reduce inflammation	0.79
be used in kawasaki disease	0.78
be recommended for diabetes	0.76
inhibit symptoms of rheumatoid arthritis	0.75

0.76

Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.91

Evidence: 0.96

Typical(aspirin, reduce cancer risk) ⋁

Evidence: 0.60

¬ Typical(aspirin, reduce risk)

0.75

Rule weight: 0.85
Evidence weight: 0.97
Similarity weight: 0.91

Evidence: 0.87

Salient(aspirin, reduce cancer risk) ⋁

Evidence: 0.26

¬ Salient(aspirin, reduce risk)

0.74

Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.91

Evidence: 0.88

Plausible(aspirin, reduce cancer risk) ⋁

Evidence: 0.37

¬ Plausible(aspirin, reduce risk)

0.72

Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 0.88

Evidence: 0.96

Typical(aspirin, reduce cancer risk) ⋁

Evidence: 0.95

¬ Typical(aspirin, prevent cancer)

0.68

Rule weight: 0.85
Evidence weight: 0.97
Similarity weight: 0.82

Evidence: 0.96

Typical(aspirin, reduce cancer risk) ⋁

Evidence: 0.77

¬ Typical(aspirin, reduce pain)

0.67

Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.91

Evidence: 0.44

Remarkable(aspirin, reduce cancer risk) ⋁

Evidence: 0.23

¬ Remarkable(aspirin, reduce risk)

0.67

Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.88

Evidence: 0.88

Plausible(aspirin, reduce cancer risk) ⋁

Evidence: 0.89

¬ Plausible(aspirin, prevent cancer)

0.66

Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.88

Evidence: 0.87

Salient(aspirin, reduce cancer risk) ⋁

Evidence: 0.91

¬ Salient(aspirin, prevent cancer)

0.66

Rule weight: 0.85
Evidence weight: 0.97
Similarity weight: 0.79

Evidence: 0.96

Typical(aspirin, reduce cancer risk) ⋁

Evidence: 0.63

¬ Typical(aspirin, reduce inflammation)

0.65

Rule weight: 0.85
Evidence weight: 0.97
Similarity weight: 0.78

Evidence: 0.96

Typical(aspirin, reduce cancer risk) ⋁

Evidence: 0.78

¬ Typical(aspirin, be used in kawasaki disease)

0.63

Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.82

Evidence: 0.88

Plausible(aspirin, reduce cancer risk) ⋁

Evidence: 0.79

¬ Plausible(aspirin, reduce pain)

0.62

Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 0.76

Evidence: 0.96

Typical(aspirin, reduce cancer risk) ⋁

Evidence: 0.99

¬ Typical(aspirin, be recommended for diabetes)

0.62

Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.82

Evidence: 0.87

Salient(aspirin, reduce cancer risk) ⋁

Evidence: 0.90

¬ Salient(aspirin, reduce pain)

0.62

Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 0.75

Evidence: 0.96

Typical(aspirin, reduce cancer risk) ⋁

Evidence: 0.93

¬ Typical(aspirin, inhibit symptoms of rheumatoid arthritis)

0.62

Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.79

Evidence: 0.88

Plausible(aspirin, reduce cancer risk) ⋁

Evidence: 0.68

¬ Plausible(aspirin, reduce inflammation)

0.62

Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.78

Evidence: 0.87

Salient(aspirin, reduce cancer risk) ⋁

Evidence: 0.58

¬ Salient(aspirin, be used in kawasaki disease)

0.61

Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.78

Evidence: 0.88

Plausible(aspirin, reduce cancer risk) ⋁

Evidence: 0.64

¬ Plausible(aspirin, be used in kawasaki disease)

0.60

Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.79

Evidence: 0.87

Salient(aspirin, reduce cancer risk) ⋁

Evidence: 0.81

¬ Salient(aspirin, reduce inflammation)

0.57

Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.75

Evidence: 0.88

Plausible(aspirin, reduce cancer risk) ⋁

Evidence: 0.91

¬ Plausible(aspirin, inhibit symptoms of rheumatoid arthritis)

0.57

Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.76

Evidence: 0.88

Plausible(aspirin, reduce cancer risk) ⋁

Evidence: 0.96

¬ Plausible(aspirin, be recommended for diabetes)

0.56

Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.76

Evidence: 0.87

Salient(aspirin, reduce cancer risk) ⋁

Evidence: 0.99

¬ Salient(aspirin, be recommended for diabetes)

0.56

Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.75

Evidence: 0.87

Salient(aspirin, reduce cancer risk) ⋁

Evidence: 0.97

¬ Salient(aspirin, inhibit symptoms of rheumatoid arthritis)

0.53

Rule weight: 0.85
Evidence weight: 0.70
Similarity weight: 0.88

Evidence: 0.44

Remarkable(aspirin, reduce cancer risk) ⋁

Evidence: 0.53

¬ Remarkable(aspirin, prevent cancer)

0.52

Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.78

Evidence: 0.44

Remarkable(aspirin, reduce cancer risk) ⋁

Evidence: 0.38

¬ Remarkable(aspirin, be used in kawasaki disease)

0.44

Rule weight: 0.85
Evidence weight: 0.69
Similarity weight: 0.76

Evidence: 0.44

Remarkable(aspirin, reduce cancer risk) ⋁

Evidence: 0.56

¬ Remarkable(aspirin, be recommended for diabetes)

0.39

Rule weight: 0.85
Evidence weight: 0.56
Similarity weight: 0.82

Evidence: 0.44

Remarkable(aspirin, reduce cancer risk) ⋁

Evidence: 0.78

¬ Remarkable(aspirin, reduce pain)

0.38

Rule weight: 0.85
Evidence weight: 0.59
Similarity weight: 0.75

Evidence: 0.44

Remarkable(aspirin, reduce cancer risk) ⋁

Evidence: 0.73

¬ Remarkable(aspirin, inhibit symptoms of rheumatoid arthritis)

0.38

Rule weight: 0.85
Evidence weight: 0.56
Similarity weight: 0.79

Evidence: 0.44

Remarkable(aspirin, reduce cancer risk) ⋁

Evidence: 0.79

¬ Remarkable(aspirin, reduce inflammation)

Parents	treatment Weight: 0.67 , medication Weight: 0.66 , substance Weight: 0.64 , ingredient Weight: 0.62 , item Weight: 0.61
Siblings	ibuprofen Weight: 0.38 , acetaminophen Weight: 0.38 , warfarin Weight: 0.37 , naproxen Weight: 0.37 , acne medication Weight: 0.36

aspirin: reduce cancer risk

Related concepts

Related properties

Priors about this statement

Cues

Evidence

Clauses

Remarkability exclusitivity between siblings

Remarkability from sibling implausibility

Salient implies Plausible

Similarity expansion

Typical and Remarkable implies Salient

Typical implies Plausible

Typicality and Rermarkability incompatibility between siblings